Results
Type
Country of origin
Qualifications

Lenvatinib | compare suppliers & send inquiries for free

Here you will find a list of producers, manufacturers and traders of Lenvatinib. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
Shandong Octagon Chemicals Limited

MOQ: 1 g
Type: Producer
Origin: China
China
Apino Pharma Co., Ltd.

MOQ: 1 kg
Type: Producer
Origin: China
China
MSN Labs.

MOQ: 0 kg
Type: Producer
Origin: India
India
R&S Chemicals

MOQ: 100 g
Type: Producer
Origin: United States
United States
Shanghai Bocimed Pharmaceutical Co., Ltd.

MOQ: 1 kg
Type: Producer
Origin: China
China
Dr. Reddy's


Type: Producer
Origin: India
India
Shilpa Medicare


Type: Producer
Origin: India
India
Beijing Mesochem Technology Co Ltd


Type: Producer
Origin: China
China
Hunan Ouya Biological Co., Ltd.


Type: Producer
Origin: China
China

Looking for Lenvatinib 417716-92-8?

API | Excipient name:
Lenvatinib 
Synonyms:
Lenvatinib Mesylate  
Cas Number:
417716-92-8 
DrugBank number:
DB09078 
Unique Ingredient Identifier:
EE083865G2

About Lenvatinib

Here you will find more information about Lenvatinib. Lenvatinib is a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib also inhibits other RTKs that have been implicated in pathogenic angiogenesis, tumor growth, and cancer progression in addition to their normal cellular functions, including fibroblast growth factor (FGF) receptors FGFR1, and 4; the platelet derived growth factor receptor alpha (PDGFRα), KIT, and RET. These receptor tyrosine kinases (RTKs) located in the cell membrane play a central role in the activation of signal transduction pathways involved in the normal regulation of cellular processes, such as cell proliferation, migration, apoptosis and differentiation, and in pathogenic angiogenesis, lymphogenesis, tumour growth and cancer progression.

In particular, VEGF has been identified as a crucial regulator of both physiologic and pathologic angiogenesis and increased expression of VEGF is associated with a poor prognosis in many types of cancers. Lenvatinib is indicated for the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer. Most patients with thyroid cancer have a very good prognosis with treatment (98% 5 year survival rate) involving surgery and hormone therapy. However, for patients with RAI-refractory thyroid cancer, treatment options are limited and the prognosis is poor, leading to a push for the development of more targeted therapies such as lenvatinib.

Ask the supplier for a certificate of analysis to find out more about the quality of Lenvatinib.

Lenvatinib manufacturers | traders | suppliers
We have 9 companies offering Lenvatinib from 3 different countries.

Get in contact with the supplier of your choice:

  • Shandong Octagon Chemicals Limited from China
  • Apino Pharma Co., Ltd. from China
  • MSN Labs. from India
  • R&S Chemicals from United States
  • Shanghai Bocimed Pharmaceutical Co., Ltd. from China
  • Shilpa Medicare from India
  • Dr. Reddy's from India
  • Beijing Mesochem Technology Co Ltd from China
  • Hunan Ouya Biological Co., Ltd. from China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.